Twist Bioscience (TWST) Non-Current Assets (2018 - 2026)

Twist Bioscience (TWST) has reported Non-Current Assets for 9 consecutive years, with $352.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Assets rose 37.17% year-over-year to $352.8 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 22.12% YoY), while the FY2025 annual figure was $308.9 million, up 15.45% from the prior year.
• Non-Current Assets climbed to $352.8 million in Q1 2026 per TWST's latest filing, from $334.2 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $368.1 million in Q4 2022 and bottomed at $257.2 million in Q1 2025.
• Historically, Non-Current Assets has averaged $327.3 million across 5 years, with a median of $342.6 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 415.6% — and 2024, when it slipped 24.26%.
• Twist Bioscience's Non-Current Assets stood at $368.1 million in 2022, then fell by 6.93% to $342.6 million in 2023, then slipped by 23.15% to $263.3 million in 2024, then grew by 26.94% to $334.2 million in 2025, then grew by 5.56% to $352.8 million in 2026.
• Business Quant data shows TWST's Non-Current Assets at $352.8 million in Q1 2026, $334.2 million in Q4 2025, and $308.9 million in Q3 2025.